A prospective, single-center, phase II study of neoadjuvant treatment with Ivonescimab (AK112) plus chemotherapy in patients with locally advanced colorectal cancer.
Active, not recruitingChiCTR2400094505
The second hospital of Lanzhou UniversityColorectal cancer
Start: 2024-12-26Updated: 2025-01-06